We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
- Authors
Jørgensen, S. F.; Macpherson, M. E.; Bjørnetrø, T.; Holm, K.; Kummen, M.; Rashidi, A.; Michelsen, A. E.; Lekva, T.; Halvorsen, B.; Trøseid, M.; Mollnes, T. E.; Berge, R. K.; Yndestad, A.; Ueland, T.; Karlsen, T. H.; Aukrust, P.; Hov, J. R.; Fevang, B.
- Abstract
This document is a retraction note for an article titled "Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency" published in Scientific Reports. The authors have retracted the article because they discovered that 26% of the participants in the trial may have been using probiotics, which was an exclusion criterion. This discovery would lower the statistical power of the trial below 80%. All authors agree to the retraction.
- Subjects
COMMON variable immunodeficiency; GUT microbiome; RANDOMIZED controlled trials; RIFAXIMIN; PROBIOTICS
- Publication
Scientific Reports, 2024, Vol 14, Issue 1, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-024-54117-6